Clinical Trials Logo

Clinical Trial Summary

The purpose of this trial is to investigate the efficiency of pain relief and the safety of NPC-06 for the acute pain in herpes zoster in the placebo-controlled double-blind parallel group trial, in addition to explore the effective concentration of NPC-06.


Clinical Trial Description

The eligible patients will be randomized into three groups, and will receive single doses of NPC-06 (high dose and low dose) or placebo. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04139330
Study type Interventional
Source Nobelpharma
Contact
Status Terminated
Phase Phase 2
Start date November 21, 2019
Completion date February 28, 2021

See also
  Status Clinical Trial Phase
Completed NCT05480553 - NPC-06 to Pain Associated With Acute Herpes Zoster Phase 3